BRF2 and breast carcinoma: The observed statistically significant overexpression of BRF2 in intraductal cribriform breast adenocarcinoma, p = 9.34E-7 (Fig. 1d), prompted a more detailed look at BRF2 alterations in subtypes of breast cancer (Fig. 2).